Author:
Luo Bo,Zheng Hongmei,Liang Gai,Luo Yan,WU Xinhong,Zhang Qu
Reference36 articles.
1. Triple negative breast cancer: Pitfalls and progress;P Zagami;NPJ Breast Cancer,2022
2. Pembrolizumab plus chemotherapy in Japanese patients with triple-negative breast cancer: Results from KEYNOTE-355;M Hattori;Cancer Med,2023
3. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer;IMpassion130 Trial Investigators,2018